CME vs TECH · P/E 22, rev $6.52B vs P/E 65, rev $1.22B
CME Group Inc (CME) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CME revenue for 2025-12-31 was $6.52B. Net income was $4.07B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CME currently screens at market cap $91.25B and trailing P/E 21.9. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CME and TECH stock pages for the full models.
Not investment advice.